イリノイ州における脳腫瘍の臨床試験
イリノイ州内の拠点で、脳腫瘍に関する14件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Saint Anthony's Health, Alton
- Rush - Copley Medical Center, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- 他33件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- University of Chicago, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT02747303A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University of Chicago, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Carle Cancer Center, Urbana
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05386108Targeted Pediatric High-Grade Glioma Therapy
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/01更新 · NCT06161974A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- Robert H. Lurie Comprehensive Cancer Center Northwestern University, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06764940Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Lurie Children's Hospital, Chicago
被験者募集中第2相
1歳〜26歳 · 全性別 · 2026/08/04更新 · NCT07680439REMASTer: REcurrent Brain Metastases After SRS Trial
- University of Chicago, Chicago
被験者募集中
18歳以上 · 全性別 · 2026/06/18更新 · NCT05124912Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- Decatur Memorial Hospital, Decatur
- HSHS Saint Elizabeth's Hospital, O'Fallon
- Methodist Medical Center of Illinois, Peoria
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/09更新 · NCT03550391Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/05/29更新 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Northwestern Memorial Hospital, Chicago
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery
- University of Illinois at Chicago, Chicago
被験者募集中
18歳〜99歳 · 全性別 · 2025/11/12更新 · NCT07111182S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- John H Stroger Jr Hospital of Cook County, Chicago
- Decatur Memorial Hospital, Decatur
- Loyola University Medical Center, Maywood
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。